Laumas Sandeep
CIK 0001721664
CFO and CBODirector
Filings
14
Latest May 18, 2026
Issuers covered
3
Showing
14 of 14
Page 1
Track record
2 of 2 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 100% | +16.3% | +16.3% | +16.3% | +16.3% |
| 90 days | 2 | 100% | +52.0% | +52.0% | +52.0% | +52.0% |
| 180 days | 2 | 100% | +61.3% | +61.3% | +61.3% | +61.3% |
| 365 days | - | - | - | - | - | - |
Issuers
Companies where Laumas Sandeep has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| TIL | Instil Bio, Inc. | 7 | Sep 12, 2025 |
| BTAI | Bioxcel Therapeutics, Inc. | 4 | Jan 12, 2026 |
| UNCY | Unicycive Therapeutics, Inc. | 3 | May 18, 2026 |
All filings
14 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|